OBCTor

OBCTor is pioneering the world’s first non-invasive Continuous Fat Monitor (CFM), delivering real-time insight into fat gain and loss trends non-invasively — using body fluids biomarkers — empowering proactive management of cardiovascular and metabolic health. Transforming Fat Loss and Cardiovascular Health Through Real-Time Biosensing OBCTor’s wearable biosensor tracks fat metabolism continuously and non-invasively, giving patients and providers real-time insight into fat trend dynamics and treatment response. Excess fat, especially visceral fat, is a major driver of cardiovascular disease, diabetes, and other chronic conditions. Yet until now, there’s been no scalable way to measure fat loss or gain as it happens. OBCTor bridges that gap by translating metabolic signals into personalized, actionable data. 🧪 Backed by science and execution Completed proof-of-concept trials in mice and humans Granted two competitive Israeli Innovation Authority awards Developed lab prototypes that track fat trends non-invasively — using body fluids biomarkers 🧠 Led by experience Founded by Nilio Eckstein, a veteran systems engineer and digital health CEO with 40+ years of experience in algorithm development, signal processing, and multidisciplinary innovation. OBCTor is supported by leading experts in obesity care, biosensor chemistry, and endocrinology from Israel and the U.S. 🎯 Our Vision To make fat trend tracking as routine — and as actionable — as glucose monitoring, enabling sustainable fat loss, disease prevention, and better health outcomes. 💡 Strategic Growth Opportunity OBCTor is actively engaging with investors and partners to support our next phase of growth — including R&D, IP development, and pre-clinical trials. ➔ Contact us: niki@obctor.com ➔ Learn more: www.obctor.com